Ironwood Pharmaceuticals IRWD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $104.45M+423% | $26.29M+2,888% | $28.55M+1,015% | -$7.89M-210% | -$32.34M+97.0% | ||
| $1.85M-6.7% | $1.88M-6.5% | $1.91M-6.5% | $1.94M-4.9% | $1.98M+9.7% | ||
| $15.61M-41.7% | $17.25M-42.2% | $17.99M-47.1% | $22.71M-32.3% | $26.76M-19.6% | ||
| —— | —— | —— | —— | $78.52M-47.0% | ||
| —— | $35K-75.4% | $35K-90.1% | $49K-87.3% | $105K-68.0% | ||
| —— | -$35K+75.4% | -$35K+99.2% | -$49K+99.8% | -$105K+100.0% | ||
| —— | $216K+100% | -$14.79M— | -$41.95M— | -$91.41M— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
